Ru Wei PhD is a Scientific Director specializing in the biopharmaceutics industry, with extensive expertise in proteomics and metabolomics/lipidomics. They previously held roles at Biogen, where they led technology development supporting drug discovery and biomarker research, and at Pfizer Pharmaceuticals, where they built the proteomics and metabolomics group. Ru Wei's earlier experience includes a position at The Broad Institute, where they established a metabolomics platform. Currently, they are pursuing advanced degrees in Instrumental Analytical Chemistry and Analytical Chemistry and Kinetic Modeling. Renowned for their innovative contributions, Ru Wei is recognized as a supportive leader and excellent team manager.
This person is not in the org chart
This person is not in any teams
This person is not in any offices